Understanding the Complex of Suicide in Depression: from Research to Clinics

키워드

참고문헌 (184)

1. Bertolote JM, "A global perspective in the epidemiology of suicide", Suicidology, 7, pp.6~8 (2002)
2. Hawton K, "Suicide", Lancet, 373, pp.1372~1381 (2009)
3. "Mental Health Atlas 2017" (2018)[URL]
4. "Preventing Suicide: A Technical Package of Policies, Programs, and Practices" (2017)[URL]
5. Chesney E, "Risks of all-cause and suicide mortality in mental disorders : a meta-review", World Psychiatry, 13, pp.153~160 (2014)
6. Andrade L, "The epidemiology of major depressive episodes : results from the International Consortium of Psychiatric Epidemiology(ICPE)Surveys", Int J Methods Psychiatr Res, 12, pp.3~21 (2003)
7. Schmidt HD, "Functional biomarkers of depression : diagnosis, treatment, and pathophysiology", Neuropsychopharmacology, 36, pp.2375~2394 (2011)
8. Ferrari AJ, "Global variation in the prevalence and incidence of major depressive disorder : a systematic review of the epidemiological literature", Psychol Med, 43, pp.471~481 (2013)
9. Mann JJ, "A current perspective of suicide and attempted suicide", Ann Intern Med, 136, pp.302~311 (2002)
10. Coryell W, "Clinical predictors of suicide in primary major depressive disorder", J Clin Psychiatry, 66, pp.412~417 (2005)
11. Ponsoni A, "Self-reported inhibition predicts history of suicide attempts in bipolar disorder and major depression", Compr Psychiatry, 82, pp.89~94 (2018)
12. Pfeiffer PN, "Comorbid anxiety as a suicide risk factor among depressed veterans", Depress Anxiety, 26, pp.752~757 (2009)
13. Abreu LN, "Are comorbid anxiety disorders a risk factor for suicide attempts in patients with mood disorders? A two-year prospective study", Eur Psychiatry, 47, pp.19~24 (2018)
14. Pompili M, "The hypothalamic-pituitary-adrenal axis and serotonin abnormalities : a selective overview for the implications of suicide prevention", Eur Arch Psychiatry Clin Neurosci, 260, pp.583~600 (2010)
15. Bun-Hee Lee, "The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment", PSYCHIATRY INVESTIGATION, 7(4), pp.231~235 (2010), 대한신경정신의학회
16. Van Heeringen K, "The neurobiology of suicide", Lancet Psychiatry, 1, pp.63~72 (2014)
17. "Suicide rising across the US More than a mental health concern"[URL]
18. Eikelenboom M, "A 6-year longitudinal study of predictors for suicide attempts in major depressive disorder", Psychol Med, 49, pp.911~921 (2019)
19. Brent DA, "Family genetic studies, suicide, and suicidal behavior", Am J Med Genet Part C. Semin Med Genet, 133C, pp.13~24 (2005)
20. Statham DJ, "Suicidal behaviour: an epidemiological and genetic study", Psychol Med, 28, pp.839~855 (1998)
21. Glowinski AL, "Suicide attempts in an adolescent female twin sample", J Am Acad Child Adolesc Psychiatry, 40, pp.1300~1307 (2001)
22. Fu Q, "A twin study of genetic and environmental influences on suicidality in men", Psychol Med, 32, pp.11~24 (2002)
23. Voracek M, "Genetics of suicide : a systematic review of twin studies", Wien Klin Wochenschr, 119, pp.463~475 (2007)
24. Brent DA, "Familial transmission of suicidal behavior", Psychiatr Clin North Am, 31, pp.157~177 (2008)
25. Tidemalm D, "Familial clustering of suicide risk: a total population study of 11.4 million individuals", Psychol Med, 41, pp.2527~2534 (2011)
26. Schosser A, "Genomewide association scan of suicidal thoughts and behaviour in major depression", PLoS One, 6, pp.e20690~ (2011)
27. Willour VL, "A genome-wide association study of attempted suicide", Mol Psychiatry, 17, pp.433~444 (2012)
28. Mullins N, "Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study", Am J Med Genet B Neuropsychiatr Genet, 165B, pp.428~437 (2014)
29. Galfalvy H, "A genome-wide association study of suicidal behavior", Am J Med Genet B Neuropsychiatr Genet, 168, pp.557~563 (2015)
30. Stein MB, "Genomewide association studies of suicide attempts in US soldiers", Am J Med Genet B Neuropsychiatr Genet, 174, pp.786~797 (2017)
31. Mullins N, "GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores", Am J Psychiatry, 176, pp.651~660 (2019)
32. Butler AW, "A genomewide linkage study on suicidality in major depressive disorder confirms evidence for linkage to 2p12", Am J Med Genet B Neuropsychiatr Genet, 153B, pp.1465~1473 (2010)
33. Erlangsen A, "Genetics of suicide attempts in individuals with and without mental disorders: a population-based genome-wide association study", Mol Psychiatry (2018)
34. Ruderfer DM, "Significant shared heritability underlies suicide attempt and clinically predicted probability of attempting suicide", Mol Psychiatry (2019)
35. Hirata T, "Major depressive disorder-associated SIRT1 locus affects the risk for suicide in women after middle age", Psychiatry Res, 278, pp.141~145 (2019)
36. Binder EB, "The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders", Psychoneuroendocrinology, 34(Suppl 1), pp.S186~S195 (2009)
37. Fries GR, "The FKBP51 Glucocorticoid receptor co-chaperone: regulation, function, and implications in health and disease", Int J Mol Sci, 18(12), pp.pii: E2614~ (2017)
38. Zannas AS, "Gene-stress-epigenetic regulation of fkbp5 : clinical and translational implications", Neuropsychopharmacology, 41, pp.261~274 (2016)
39. Appel K, "Moderation of adult depression by a polymorphism in the FKBP5gene and childhood physical abuse in the general population", Neuropsychopharmacology, 36, pp.1982~1991 (2011)
40. Kohrt BA, "Cross-cultural gene-environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response : FKBP5 polymorphisms and childhood trauma in South Asia", Int Rev Psychiatry, 27, pp.180~196 (2015)
41. Tozzi L, "Single-nucleotide polymorphism of the fkbp5 gene and childhood maltreatment as predictors of structural changes in brain areas involved in emotional processing in depression", Neuropsychopharmacology, 41, pp.487~497 (2016)
42. Yeo S, "The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoidregulated genes, dependent on trauma exposure", Genes Brain Behav, 16, pp.223~232 (2017)
43. Hernández-Díaz Y, "Association between FKBP5 polymorphisms and depressive disorders or suicidal behavior : a systematic review and meta-analysis study", Psychiatry Res, 271, pp.658~668 (2019)
44. Gonda X, "The possible contributory role of the S allele of 5-HTTLPR in the emergence of suicidality", J Psychopharmacol, 25, pp.857~866 (2011)
45. Antypa N, "Serotonergic genes and suicide : a systematic review", Eur Neuropsychopharmacol, 23, pp.1125~1142 (2013)
46. Daws LC, "Electrochemical Methods for Neuroscience", pp.63~81 (2007)
47. Purselle DC, "Serotonin transporter : a potential substrate in the biology of suicide", Neuropsychopharmacology, 28, pp.613~619 (2003)
48. Levey DF, "Genetic associations with suicide attempt severity and genetic overlap with major depression", Transl Psychiatry, 9, pp.22~ (2019)
49. Fanelli G, "The influence of the serotonin transporter gene 5-HTTLPR polymorphism on suicidal behaviors : a meta-analysis", Prog Neuropsychopharmacol Biol Psychiatry, 88, pp.375~387 (2019)
50. Ludwig B, "The life span model of suicide and its neurobiological foundation", Front Neurosci, 11, pp.74~ (2017)
51. Turecki G, "The neurodevelopmental origins of suicidal behavior", Trends Neurosci, 35, pp.14~23 (2012)
52. Booij L, "Looking beyond the DNA sequence : the relevance of DNA methylation processes for the stress-diathesis model of depression", Philos Trans R Soc Lond B Biol Sci, 368, pp.20120251~ (2013)
53. Brown A, "Bridging basic and clinical research in early life adversity, DNA methylation, and major depressive disorder", Front Genet, 10, pp.229~ (2019)
54. Roy B, "DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation", J Psychiatr Res, 89, pp.115~124 (2017)
55. Duman RS, "A molecular and cellular theory of depression", Arch Gen Psychiatry, 54, pp.597~606 (1997)
56. Arato M, "Elevated CSF CRF in suicide victims", Biol Psychiatry, 25, pp.355~359 (1989)
57. Coryell W, "The dexamethasone suppression test and suicide prediction", Am J Psychiatry, 158, pp.748~753 (2001)
58. Kunugi H, "Combined DEX", CRH test among Japanese patients with major depression, 2004, pp.38, 123~128
59. Yerevanian BI, "The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression", J Affect Disord, 83, pp.103~108 (2004)
60. Jokinen J, "ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide", J Affect Disord, 106, pp.145~152 (2008)
61. Underwood MD, "Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims", Biol Psychiatry, 46, pp.473~483 (1999)
62. Boldrini M, "More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides", Brain Res, 1041, pp.19~28 (2005)
63. Bonkale WL, "Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus", Synapse, 60, pp.81~85 (2006)
64. Asberg M, "5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?", Arch Gen Psychiatry, 33, pp.1193~1197 (1976)
65. Mann JJ, "Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies", Br J Psychiatry Suppl, (8), pp.7~14 (1989)
66. Mann JJ, "A serotonin transporter gene promoter polymorphism(5-HTTLPR)and prefrontal cortical binding in major depression and suicide", Arch Gen Psychiatry, 57, pp.729~738 (2000)
67. Hou C, "CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder", Brain Res, 1095, pp.154~158 (2006)
68. Leake A, "Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain : neurochemical and clinical correlates", Psychiatry Res, 39, pp.155~165 (1991)
69. Arango V, "Autoradiographic demonstration of increased serotonin 5-HT2and beta-adrenergic receptor binding sites in the brain of suicide victims", Arch Gen Psychiatry, 47, pp.1038~1047 (1990)
70. Pandey GN, "Higher expression of serotonin 5-HT(2A)receptors in the postmortem brains of teenage suicide victims", Am J Psychiatry, 159, pp.419~429 (2002)
71. Mann JJ, "Can biological tests assist prediction of suicide in mood disorders", Int J Neuropsychopharmacol, 9, pp.465~474 (2006)
72. Gaysina D, "The serotonin transporter gene : polymorphism and haplotype analysis in Russian suicide attempters", Neuropsychobiology, 54, pp.70~74 (2006)
73. Agargun MY, "REM sleep, dream variables and suicidality in depressed patients", Psychiatry Res, 119, pp.33~39 (2003)
74. Singareddy RK, "Sleep and suicide in psychiatric patients", Ann Clin Psychiatry, 13, pp.93~101 (2001)
75. Chen B, "Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication", Biol Psychiatry, 50, pp.260~265 (2001)
76. Chen YY, "Suicide prevention is not just about treating depression", Inj Prev, 12, pp.208~ (2006)
77. Grah M, "Brain-derived neurotrophic factor as a suicide factor in mental disorders", Acta Neuropsychiatr, 26, pp.356~363 (2014)
78. Eisen RB, "Association between BDNF levels and suicidal behaviour : a systematic review and meta-analysis", Syst Rev, 4, pp.187~ (2015)
79. Eisen RB, "Exploring the association between serum BDNF and attempted suicide", Sci Rep, 6, pp.25229~ (2016)
80. Castren E, "Brain-derived neurotrophic factor in mood disorders and antidepressant treatments", Neurobiol Dis, 97, pp.119~126 (2017)
81. Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
82. Huang TL, "Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients", J Psychiatr Res, 40, pp.664~668 (2006)
83. Dwivedi Y, "The Neurobiological Basis of Suicide" (2012)
84. Garcia R, "Stress, synaptic plasticity, and psychopathology", Rev Neurosci, 13, pp.195~208 (2002)
85. Wagner G, "Prefrontal cortical thickness in depressed patients with high-risk for suicidal behavior", J Psychiatr Res, 46, pp.1449~1455 (2012)
86. Sher L, "Brain-derived neurotrophic factor and suicidal behavior", QJM, 104, pp.455~458 (2011)
87. Paska AV, "The role of brain-derived neurotrophic factor in the pathophysiology of suicidal behavior", Psychiatr Danub, 25(Suppl 2), pp.S341~S344 (2013)
88. Lee BH, "Potential peripheral biological predictors of suicidal behavior in major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.842~847 (2011)
89. Kim YK, "Low plasma BDNF is associated with suicidal behavior in major depression", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.78~85 (2007)
90. Khan MS, "Low serum brain-derived neurotrophic factor is associated with suicidal ideation in major depressive disorder", Psychiatry Res, 273, pp.108~113 (2019)
91. Duman RS, "Neural plasticity to stress and antidepressant treatment", Biol Psychiatry, 46, pp.1181~1191 (1999)
92. Manji HK, "The cellular neurobiology of depression", Nat Med, 7, pp.541~547 (2001)
93. Neves-Pereira M, "The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder : evidence from a family-based association study", Am J Hum Genet, 71, pp.651~655 (2002)
94. Sklar P, "Family-based association study of 76 candidate genes in bipolar disorder:BDNF is a potential risk locus. Brain-derived neutrophic factor", Mol Psychiatry, 7, pp.579~593 (2002)
95. Egan MF, "The BDNF val66met polymorphism affects activitydependent secretion of BDNF and human memory and hippocampal function", Cell, 112, pp.257~269 (2003)
96. Dowlatshahi D, "G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders : effects of diagnosis, suicide, and treatment at the time of death", J Neurochem, 73, pp.1121~1126 (1999)
97. Dwivedi Y, "Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects", Arch Gen Psychiatry, 60, pp.273~282 (2003)
98. Young LT, "Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders : effects of diagnosis, suicide, and drug treatment", Biol Psychiatry, 55, pp.570~577 (2004)
99. Carlberg L, "Association study of CREB1 polymorphisms and suicidality in MDD : results from a European multicenter study on treatment resistant depression", Int J Neurosci, 125, pp.336~343 (2015)
100. Martino M, "NGF serum levels variations in major depressed patients receiving duloxetine", Psychoneuroendocrinology, 38, pp.1824~1828 (2013)
101. Banerjee R, "Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide : an analysis in human postmortem brain", Clin Med Insights Pathol, 6, pp.1~11 (2013)
102. Dwivedi Y, "Suicide brain is associated with decreased expression of neurotrophins", Biol Psychiatry, 58, pp.315~324 (2005)
103. Diniz BS, "Reduced serum nerve growth factor in patients with latelife depression", Am J Geriat Psychiatry, 21, pp.493~496 (2013)
104. Wiener CD, "Serum levels of nerve growth factor(NGF)in patients with major depression disorder and suicide risk", J Affect Disord, 184, pp.245~248 (2015)
105. Serafini G, "The role of inflammatory cytokines in suicidal behavior : a systematic review", Eur Neuropsychopharmacol, 23, pp.1672~1686 (2013)
106. Black C, "Meta-analysis of cytokines and chemokines in suicidality : distinguishing suicidal versus nonsuicidal patients", Biol Psychiatry, 78, pp.28~37 (2015)
107. Courtet P, "Neuroinflammation in suicide : toward a comprehensive model", World J Biol Psychiatry, 17, pp.564~586 (2016)
108. Gabbay V, "A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression", J Child Adolesc Psychopharmacol, 19, pp.423~430 (2009)
109. Vargas HO, "Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts", J Affect Disord, 150, pp.923~930 (2013)
110. Marini S, "Inflammatory markers and suicidal attempts in depressed patients : A review", Int J Immunopathol Pharmacol, 29, pp.583~594 (2016)
111. Frick MH, "Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease", N Engl J Med, 317, pp.1237~1245 (1987)
112. Muldoon MF, "Lowering cholesterol concentrations and mortality : a quantitative review of primary prevention trials", BMJ, 301, pp.309~314 (1990)
113. De Berardis D, "The role of cholesterol levels in mood disorders and suicide", J Biol Regul Homeost Agents, 23, pp.133~140 (2009)
114. De Berardis D, "The relationships between cholesterol and suicide : an update", ISRN Psychiatry, 2012, pp.387901~ (2012)
115. Segoviano-Mendoza M, "Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population", BMC Psychiatry, 18, pp.7~ (2018)
116. Kunugi H, "Low serum cholesterol in suicide attempters", Biol Psychiatry, 41, pp.196~200 (1997)
117. Papassotiropoulos A, "The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol", Pharmacopsychiatry, 32, pp.1~4 (1999)
118. Alvarez JC, "Low serum cholesterol in violent but not in non-violent suicide attempters", Psychiatry Res, 95, pp.103~108 (2000)
119. Kim YK, "Low serum cholesterol is correlated to suicidality in a Korean sample", Acta Psychiatr Scand, 105, pp.141~148 (2002)
120. Lee HJ, "Serum lipid levels and suicide attempts", Acta Psychiatr Scand, 108, pp.215~221 (2003)
121. Misiak B, "Lipid profile disturbances in antipsychotic-naive patients with first-episode nonaffective psychosis : a systematic review and meta-analysis", Schizophr Res, 190, pp.18~27 (2017)
122. Vuksan-Cusa B, "Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts", Acta Neuropsychiatr, 21(Suppl 2), pp.66~69 (2009)
123. Da Graca Cantarelli M, "CA. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders", J Affect Disord, 172, pp.403~409 (2015)
124. Budania S, "Serum cholesterol and depression : an update", Med J, 7, pp.543~549 (2014)
125. Wallner B, "The evolution of violence in men : the function of central cholesterol and serotonin", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.391~397 (2009)
126. Rock PL, "Cognitive impairment in depression : a systematic review and meta-analysis", Psychol Med, 44, pp.2029~2040 (2014)
127. Austin MP, "Cognitive deficits in depression : possible implications for functional neuropathology", Br J Psychiatry, 178, pp.200~206 (2001)
128. Marzuk PM, "Executive functioning in depressed patients with suicidal ideation", Acta Psychiatr Scand, 112, pp.294~301 (2005)
129. Hammar A, "Cognitive functioning in major depression-a summary", Front Hum Neurosci, 3, pp.26~ (2009)
130. Pu S, "Association between cognitive deficits and suicidal ideation in patients with major depressive disorder", Sci Rep, 7, pp.11637~ (2017)
131. Braver TS, "The variable nature of cognitive control : a dual mechanisms framework", Trends Cogn Sci, 16, pp.106~113 (2012)
132. Paulus MP, "Cognitive control in depression and anxiety : out of control", Current Opinion in Behavioral Sciences, 1, pp.113~120 (2015)
133. McGirr A, "Deterministic learning and attempted suicide among older depressed individuals : cognitive assessment using the Wisconsin Card Sorting Task", J Psychiatr Res, 46, pp.226~232 (2012)
134. Westheide J, "Executive performance of depressed suicide attempters : the role of suicidal ideation", Eur Arch Psychiatry Clin Neurosci, 258, pp.414~421 (2008)
135. Huang H, "The influence of depression on cognitive control : disambiguating approach and avoidance tendencies", PLoS One, 10, pp.e0143714~ (2015)
136. Gorlyn M, "Treatment-related improvement in neuropsychological functioning in suicidal depressed patients : paroxetine vs. bupropion", Psychiatry Res, 225, pp.407~412 (2015)
137. Richard-Devantoy S, "A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders", Psychol Med, 44, pp.1663~1673 (2014)
138. Keilp JG, "Neuropsychological dysfunction in depressed suicide attempters", Am J Psychiatry, 158, pp.735~741 (2001)
139. Roiser JP, "Hot and cold cognition in depression", CNS spectrums, 18, pp.139~149 (2013)
140. Snyder HR, "Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function : a meta-analysis and review", Psychol Bull, 139, pp.81~132 (2013)
141. Bortolato B, "Cognitive dysfunction in major depressive disorder : a state-of-the-art clinical review", CNS Neurolog Disorders Drug Targets, 13, pp.1804~1818 (2014)
142. Snyder HR, "Advancing understanding of executive function impairments and psychopathology : bridging the gap between clinical and cognitive approaches", Front Psychol, 6, pp.328~ (2015)
143. Ho MC, "‘Cool’ and ‘Hot’ executive functions in suicide attempters with major depressive disorder", J Affect Disord, 235, pp.332~340 (2018)
144. Erić AP, "The temperament and character traits in patients with major depressive disorder and bipolar affective disorder with and without suicide attempt", Psychiatr Danub, 29, pp.171~178 (2017)
145. Cloninger CR, "A psychobiological model of temperament and character", Arch Gen Psychiatry, 50, pp.975~990 (1993)
146. De Berardis D, "Alexithymia and suicide risk in psychiatric disorders : a mini-review", Front Psychiatry, 8, pp.148~ (2017)
147. Domenico De Berardis, "Alexithymia, Suicide Ideation and Homocysteine Levels in Drug Naïve Patients with Major Depression: A Study in the “Real World” Clinical Practice", Clinical Psychopharmacology and Neuroscience, 17(2), pp.318~322 (2019), 대한정신약물학회[DOI]
148. Bani-Fatemi A, "Structural and functional alterations of the suicidal brain : An updated review of neuroimaging studies", Psychiatry Res Neuroimaging, 278, pp.77~91 (2018)
149. Desmyter S, "Structural and functional neuroimaging studies of the suicidal brain", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.796~808 (2011)
150. Jollant F, "The suicidal mind and brain : a review of neuropsychological and neuroimaging studies", World J Biol Psychiatry, 12, pp.319~339 (2011)
151. Van Heeringen K, "Is there a neuroanatomical basis of the vulnerability to suicidal behavior? A coordinate-based meta-analysis of structural and functional MRI studies", Front Hum Neurosci, 22, pp.824~ (2014)
152. Cox Lippard ET, "Neurobiological risk factors for suicide : insights from brain imaging", Am J Prev Med, 47, pp.S152~S162 (2014)
153. Zhang H, "Dysfunction of neural circuitry in depressive patients with suicidal behaviors : a review of structural and functional neuroimaging studies", Prog Neuropsychopharmacol Biol Psychiatry, 53, pp.61~66 (2014)
154. Jollant F, "Biological Aspects of Suicidal Behavior. Adv Biol Psychiatry", pp.110~122 (2016), Karger
155. Vang FJ, "Size of basal ganglia in suicide attempters, and its association with temperament and serotonin transporter density", Psychiatry Res, 183, pp.177~179 (2010)
156. Dombrovski AY, "The temptation of suicide : striatal gray matter, discounting delayed rewards, and suicide attempts in late-life depression", Psychol Med, 42, pp.1203~1215 (2012)
157. Peng H, "Increased suicide attempts in young depressed patients with abnormal temporal-parietal-limbic gray matter volume", J Affect Disord, 165, pp.69~73 (2014)
158. Monkul ES, "Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder", Mol Psychiatry, 12, pp.360~366 (2007)
159. Ding Y, "Prefrontal cortex markers of suicidal vulnerability in mood disorders : a model-based structural neuroimaging study with a translational perspective", Transl Psychiatry, 5, pp.e516~ (2015)
160. Gosnell SN, "Prefrontal cortex, temporal cortex, and hippocampus volume are affected in suicidal psychiatric patients", Psychiatry Res Neuroimaging, 256, pp.50~56 (2016)
161. Hwang JP, "Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry", J Geriatr Psychiatry Neurol, 23, pp.171~184 (2010)
162. Gifuni AJ, "Subcortical nuclei volumes in suicidal behavior : nucleus accumbens may modulate the lethality of acts", Brain Imaging Behav, 10, pp.96~104 (2016)
163. Lee YJ, "Decreased regional gray matter volume in suicide attempters compared to suicide non-attempters with major depressive disorders", Compr Psychiatry, 67, pp.59~65 (2016)
164. Colle R, "Depressed suicide attempters have smaller hippocampus than depressed patients without suicide attempts", J Psychiatr Res, 61, pp.13~18 (2015)
165. Fan T, "Abnormal baseline brain activity in suicidal and non-suicidal patients with major depressive disorder", Neurosci Lett, 534, pp.35~40 (2013)
166. Cao J, "Resting-state functional MRI of abnormal baseline brain activity in young depressed patients with and without suicidal behavior", J Affect Disord, 205, pp.252~263 (2016)
167. Kang S, "Resting-state functional connectivity of the amygdala in suicide attempters with major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 77, pp.222~227 (2017)
168. Jollant F, "Orbitofrontal cortex response to angry faces in men with histories of suicide attempts", Am J Psychiatry, 165, pp.740~748 (2008)
169. Jollant F, "Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainity is associated with disadvantageous decisionmaking and suicidal behaviour", Neuroimage, 51, pp.1275~1281 (2010)
170. Pan L, "Preserved hippocampal function during learning in the context of risk in adolescent suicide attempt", Psychiatry Res, 211, pp.112~118 (2013)
171. Pan LA, "Differential patterns of activity and functional connectivity in emotion processing neural circuitry to angry and happy faces in adolescents with and without suicide attempt", Psychol Med, 43, pp.2129~2142 (2013)
172. Miller JM, "Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder", Biol Psychiatry, 74, pp.287~295 (2013)
173. Nye JA, "Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using 11C-zient PET imaging", Depress Anxiety, 30, pp.902~907 (2013)
174. Ryding E, "Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy", Psychiatry Res, 148, pp.195~203 (2006)
175. De Berardis D, "Editorial : understanding the complex phenomenon of suicide : from research to clinical practice", Front Psychiatry, 9, pp.61~ (2018)
176. Pompili M, "Critical appraisal of major depression with suicidal ideation", Ann Gen Psychiatry, 18, pp.7~ (2019)
177. Maj M, "When does depression become a mental disorder", Br J Psychiatry, 199, pp.85~86 (2011)
178. Maj M, "“Clinical judgment’’ and the DSM-5 diagnosis of major depression", World Psychiatry, 12, pp.89~91 (2013)
179. American Psychiatric Association (APA), "Diagnostic and Statistical Manual of Mental Disorders: DSM-5" (2013), American Psychiatric Publishing
180. De Berardis D, "Eradicating suicide at its roots: preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors", Int J Mol Sci, 19, pp.pii: E2888~ (2018)
181. De Berardis D, "An update on glutamatergic system in suicidal depression and on the role of esketamine", Curr Top Med Chem (2020)
182. Hawton K, "Risk factors for suicide in individuals with depression: a systematic review", J Affect Disord, 147, pp.17~28 (2013)
183. Orsolini L, "Suicide during Perinatal Period : Epidemiology, Risk Factors, and Clinical Correlates", Front Psychiatry, 7, pp.138~ (2016)
184. Fornaro M, "The FDA “Black Box” warning on antidepressant suicide risk in young adults: more harm than benefits?", Front Psychiatry, 10, pp.294~ (2019)

관련 논문AI추천